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The extent to which sleep is causally related to mental health is unclear. One way to test the causal link is
to evaluate the extent to which interventions that improve sleep quality also improve mental health. We
conducted a meta-analysis of randomised controlled trials that reported the effects of an intervention
that improved sleep on composite mental health, as well as on seven specific mental health difficulties.
65 trials comprising 72 interventions and N ¼ 8608 participants were included. Improving sleep led to a
significant medium-sized effect on composite mental health (gþ ¼ 0.53), depression (gþ ¼ 0.63),
anxiety (gþ ¼ 0.51), and rumination (gþ ¼ 0.49), as well as significant small-to-medium sized effects
on stress (gþ ¼ 0.42), and finally small significant effects on positive psychosis symptoms (gþ ¼ 0.26).
We also found a dose response relationship, in that greater improvements in sleep quality led to greater
improvements in mental health. Our findings suggest that sleep is causally related to the experience of
mental health difficulties. Future research might consider how interventions that improve sleep could be
incorporated into mental health services, as well as the mechanisms of action that explain how sleep
exerts an effect on mental health.
© 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Does improving sleep lead to better mental health? A meta-
analysis of randomised controlled trials
Problems sleeping are common. A review of several hundred
epidemiological studies [1] concluded that nearly one-third of the
general population experience symptoms of insomnia (defined as
difficulties falling asleep and/or staying asleep), between 4% and
26% experience excessive sleepiness, and between 2% and 4%
experience obstructive sleep apnoea. Additionally, a recent study of
over 2000 participants reported that the prevalence of ‘general
sleep disturbances’ was 32% [2] and Chattu et al. concluded on the
basis of a large systematic review of the evidence that public and
health professionals need to bemore aware of the adverse effects of
poor sleep [3]. Mental health problems are also common, with
around 17% of adults experiencing mental health difficulties ofothy Hodgkin Building, Keele
r Ltd. This is an open access articlevarying severities [4], and evidence from large nationally repre-
sentative studies suggesting that mental health difficulties are on
the increase [5]. Sleep and mental health are, therefore, global
public health challenges in their own right, with each having sub-
stantive impacts on both individuals and society [3,6,7]. However,
problems sleeping and mental health difficulties are also intrinsi-
cally linked [8,9]. It was previously assumed that mental health
difficulties led to problems sleeping [10,11]; however, the reverse
may also be true [12], such that poor sleep contributes to the onset,
recurrence, and maintenance of mental health difficulties [13e17].
Therefore, the extent to which there is a causal relation between
(poor) sleep and (worse) mental health and the possibility that
interventions designed to improve sleep might be able to reduce
mental health difficulties warrants investigation.Evidence on the relationship between sleep and mental health
The association between sleep and mental health is well
documented [9,13,18e23]. For example, people with insomnia areunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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experience clinically significant levels of depression and anxiety,
respectively [24]. Furthermore, a meta-analysis of 21 longitudinal
studies reported that people with insomnia at baseline had a two-
fold risk of developing depression at follow-up compared with
people who did not experience insomnia [13]. Although research
most commonly studies the associations between insomnia and
depression and anxiety, there is also evidence that problems
sleeping are associated with a variety of mental health difficulties.
For example, poor sleep has also been associated with post-
traumatic stress [25], eating disorders [26], and psychosis spec-
trum experiences such as delusions and hallucinations [23,27].
Studies have also found that specific sleep disorders, such as sleep
apnoea [28], circadian rhythm disruption [29], restless leg syn-
drome [30], excessive daytime sleepiness and narcolepsy [31,32],
sleepwalking [33], and nightmares [34] are all more prevalent in
those experiencing mental health difficulties.
Unfortunately, most research on the association between
sleep and mental health is observational in design. While infor-
mative, inferring causation from such studies is difficult. For
example, cross-sectional designs tell us that variables are asso-
ciated in some way, but they cannot say whether one variable
precedes the other in a causal chain [35]. Longitudinal designs
provide stronger evidence, but are prone to residual confounding
[36e38] and other forms of bias that limit causal inference
[39e43]. The best evidence is provided by studies that randomly
allocate participants to experimental and control conditions to
minimise the effects of potential confounds [44,45]. Therefore, to
establish whether sleeping problems are causally associated with
mental health difficulties, it is necessary to experimentally
manipulate sleep to see whether changes in sleep lead to changes
in mental health over time (i.e., the interventionist approach to
causation, [46]).
Many RCTs have examined the effect of interventions designed
to improve sleep (typically cognitive behavioural therapy for
insomnia, CBTi), on mental health (typically depression and anx-
iety). There have also been attempts to meta-analyse some of
these RCTs and quantify their effects on mental health outcomes
[47e50]. However, even these meta-analyses do not permit robust
conclusions as to the causal impact of sleep on mental health
outcomes for several reasons. First, previous reviews have
included studies that did not successfully manipulate sleep (i.e.,
the intervention did not improve sleep relative to controls). It is
not possible to conclude whether sleep is causally linked to mental
health if the experimental manipulation of sleep is unsuccessful
[51]. Indeed, these studies simply tell us that it can sometimes be
difficult to improve sleep in the first place. Second, reviews have
tended to examine the effect of interventions targeting sleep on
mental health at the first post-intervention time point. This is
problematic for two reasons; 1) there is no temporal lag between
the measurement of sleep and measurement of mental health (a
key tenet of causal inference); and 2) effects are limited to the
short-term where they are likely to be strongest. Third, the focus
of previous reviews has been limited to depression and anxiety
only, and typically limited to CBTi interventions. Therefore, the
effect of improving sleep on other mental health outcomes, using
different approaches to intervention, is limited. Finally, to date
there has been no or limited attempts to investigate variables that
influence e or moderate e the impact of interventions that
improve sleep on mental health. It is crucial that the impact of
such variables is systematically examined to understand whether
the effect of improving sleep on mental health differs across
populations, settings, and study designs.2
The present review: an interventionist approach to causation
The present review sought to address these issues to provide an
accurate and robust estimate of the effect of changes in sleep
quality (i.e., as a result of an intervention) on changes in mental
health. To test this empirically, we identified randomised controlled
trials that successfully manipulated sleep in an intervention group
relative to controls, and then measured mental health at a later
follow-up point. We did not limit the scope of interventions to CBTi,
or the measures of mental health to solely depression and/or
anxiety. Instead, we included any intervention designed to improve
sleep that produced a statistically significant effect on sleep quality
relative to controls and examined the effect of that improvement in
sleep on any subsequent mental health outcome. To better isolate
the effect of improved sleep on mental health, we excluded in-
terventions that included specific elements targetingmental health
(e.g., CBT elements for depression). Given the (potentially) high
degree of heterogeneity between studies that this approach might
create, we examined the effect of different study characteristics and
outcomes using moderation analyses. Our primary hypothesis is
that interventions that significantly improve sleep will lead to
significantly improved mental health at follow-up.
Method
Eligibility criteria
To be included in the present review, studies needed to 1) be a
randomized controlled trial that tested an intervention designed to
improve sleep; 2) produce a statistically significant effect on sleep
quality when compared to a control group or an alternative treat-
ment, 3) report a measure of mental health subsequent to the
measure of sleep quality, 4) report sufficient data to compute an
effect size representing the impact of the intervention on both sleep
quality and mental health, 5) be written in English, or translatable
using available resources. In order to reliably and validly assess the
independent contribution of changes in sleep on mental health
outcomes among adult populations, studies were excluded if 1) the
intervention contained elements that specifically target a mental
health problem in addition to elements that target sleep; or 2)
recruited children and young people (i.e., <18 years of age).
Search strategy
First, we searched MEDLINE (1946 to present), Embase (1974 to
present), PsycINFO (1967 to present), and The Cochrane Library
(1898 to present) using the Cochrane Highly Sensitive Search
Strategy (i.e., HSSS, [52]) to identify RCTs that included terms
relating to sleep quality and/or sleep disorders, and mental health
(see Table 1 for a list of the search terms and Supplementary
Material 1 for an example search strategy). Second, the reference
lists of extant reviews of the relationship between sleep andmental
health were searched for any potential articles. Third, a search for
any unpublished or ongoing studies was conducted by searching
online databases including White Rose Online, The National
Research Register, WHO approved clinical trial databases (e.g.,
ISRCTN), and PROSPERO. Searches were originally conducted in
May 2019 and then updated in February 2021.
Data management and study selection
We followed PRISMA guidelines [53] when selecting studies.
The first phase of screening removed duplicate records and records
Table 1
Search terms used to identify RCT's that examined the effect of improving sleep on
mental health.




Controlled clinical trial “Circadian rhythm” “Mental”
Randomi$ed Insomnia Psychiat*
Placebo Hypersomnia Affect*






















Notes: HSSS for RCTs ¼ highly sensitive search strategy for randomised controlled
trials, OCD ¼ obsessive compulsive disorder, PTSD ¼ post-traumatic stress disorder.
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second phase of screening cross-referenced full-text versions of
articles against the inclusion criteria, with eligible records included
in the present review, and ineligible records excluded along with
reasons for exclusion. Records were screened by two members of
the review team, and a sub-sample of 10% of each reviewer's re-
cords were second checked by the other reviewer, with almost
perfect agreement between the reviewers (kappa ¼ 1.00 and 0.99).
Data extraction
Data was extracted from included studies using a standardized
form and an accompanying manual detailing each variable for
extraction. In addition to extracting statistical data to compute ef-
fect sizes, data pertaining to source characteristics of included
studies (e.g., publication status, year, impact factor), characteristics
of the sample (e.g., age, type of mental health problem), the study
(e.g., the nature of the comparison group, length of follow-up), and
the intervention (e.g., intervention type, mode of delivery) was also
extracted.
Outcomes and prioritization
Measuring improvements in sleep
The concept of ‘improved sleep’ is multifaceted and can mean
different things to different people [54e56]. Consequently, one
challenge for the proposed review was to ensure that included
studies assessed a similar notion of improved sleep so that they
could be meaningfully combined using a single metric. Therefore,
we specified that primary studies reported a measure that reflected
the overall quality of sleep experienced by participants. The
concept of sleep quality can also be subjective [54]; however,
broadly speaking, sleep quality consists of sleep continuity (e.g.,
sleep onset, sleep maintenance, and number of awakenings) and
daytime impact (e.g., the extent to which the person feels refreshed3
on waking and throughout the day, see [54,57]). We used the
following hierarchy to decide which outcome measure(s) to use to
estimate an effect size (in descending order of prioritization); 1)
self-report measures of global sleep quality (e.g., the Pittsburgh
Sleep Quality Index); 2) outcomes specific to a given sleep disorder
that assess sleep continuity and impact on daily life (e.g., the
Insomnia Severity Index); and 3) individual components of self-
reported sleep continuity aggregated to form a single composite
effect size (e.g., the average effect of intervention on sleep onset
latency (SoL) and wake after sleep onset (WASO)).
Measuring mental health
We examined the effect of improving sleep on 1) composite
mental health (which included all mental health outcomes re-
ported across studies, see Table 2 for outcomes), and 2) specific
mental health difficulties in isolation (e.g., depression separately
from other mental health outcomes). We computed the between-
group effect of improving sleep on each mental health outcome
reported by the study at the furthest follow-up point available. This
strategy provides a stringent test of the effect of improving sleep on
mental health outcomes in the sense that any changes need to have
been maintained over time. In line with previous reviews [58],
these effect sizes were then averaged to form a ‘composite’measure
of mental health. As with the measures of sleep quality, we prior-
itized self-report measures of mental health rather than observer-
rated measures, as arguably it is the subjective experience of
mental health problems that is most important [59].
Risk of bias
Risk of bias was assessed using the risk of bias assessment
criteria developed by the Cochrane Collaboration [60]. RCTs were
classified as being at overall risk of bias according to three of the six
domains e 1) allocation concealment, 2) blinding of outcome
assessment and 3) completeness of outcome data (attrition). RCTs
judged as being at low risk of bias for all three domains were judged
at overall low risk of bias. RCTs judged as being at high risk for any
of the three domains were judged as overall high risk of bias. RCTs
judged as a mix of low and unclear risk on these three domains, or
all unclear were judged as unclear with respect to risk of bias.
Estimating effect sizes
Hedges g and the associated standard error were estimated
using the means and standard deviations reported by each of the
primary studies. Where means and standard deviations were not
reported, effect sizes were estimated by converting relevant sum-
mary statistics into Hedges g. Where studies reported multiple
outcome measures for the same/similar constructs (e.g., several
measures of depression), effect sizes were computed for each
outcome and then meta-analysed in their own right to form one
overall effect.
Meta-analytic approach
All analyses were conducted in R [61], using the ‘esc’ [62], ‘meta’
[63], ‘metafor’ [64], ‘dmetar’ [65], and ‘robvis’ [66] packages. The
pooled, sample-weighted, average effect sizewas computed using a
random effects model as effect sizes between studies are likely to
vary considerably [67]. Following Cohen's recommendations [68],
g ¼ 0.20was taken to represent a ‘small’ effect size, g ¼ 0.50 a
‘medium’ effect size and g ¼ 0.80 a ‘large’ effect size. The I2 statistic
was used to assess heterogeneity of effect sizes across the included
studies and was interpreted according to the classifications sug-
gested by Higgins et al. [69], where I2 ¼ 25% indicates low het-
erogeneity, I2¼ 50% indicates moderate heterogeneity, and I2¼ 75%
indicates high heterogeneity. Publication bias was assessed via vi-
sual inspection of a funnel plot and Egger's test [70]. Additionally,
Table 2
Summary of studies included in the review.
Author (year) Intervention Control Outcome Measure ne nc gþ
Alessi et al. (2016) [117] CBTi Sleep education Depression PHQ-9 89 51 0.20
Ashworth et al. (2015) [118] CBTi CBTi (self-help) Anxiety DASS-A 18 18 1.41***
Depression BDI 18 18 2.31***
Behrendt et al. (2020) [119] CBTi WLC Depression CES-D 46 80 0.52**
Rumination PSWQ 46 80 0.45*
Bergdahl et al. (2016) [120] CBTi Acupuncture Anxiety HADS-A 23 22 0.03
Depression HADS-D 23 22 0.06
Blom et al. (2017) [121] CBTi CBT for depression Depression MADRS 20 17 0.31
Cape et al. (2016) [122] CBTi TaU Anxiety GAD-7 91 99 0.11
Depression PHQ-9 92 100 0.20
Casault et al. (2015) [123] CBTi WLC Anxiety HADS-A 17 18 0.39
Depression HADS-D 17 18 0.11
Chang et al. (2016) [124] Herbal tea WLC Depression EPDS 35 37 0.52*
Chang et al. (2016) [125] Sleep education þ relaxation WLC Anxiety HADS-A 43 41 0.68**
Depression HADS-D 43 41 0.52*
Chao et al. (2021) [126] CBTi WLC Depression HADS-D 32 39 0.67**
Anxiety HADS-A 32 39 0.60*
Chen et al. (2009) [127] Yoga TaU Depression TDS 62 66 0.60***
Chen et al. (2019) [128] Acupuncture Sham acupuncture Mood/affect K-10 31 31 0.50
Cheng et al. (2019) [129] CBTi Sleep education Depression QIDS 358 300 0.45***
Christensen et al. (2016) [130] CBTi Health education Anxiety GAD-7 224 280 0.34***
Depression PHQ-9 224 280 0.53***
Chung et al. (2018) [131] Acupuncture WLC Anxiety HADS-A 71 32 0.37
Depression HADS-D 71 32 0.46*
Currie et al. (2000) [132] CBTi WLC Depression BDI 32 28 0.31
Edinger et al. (2005)a [133] CBTi TaU Mood/affect POMS 6 7 1.27
Edinger et al. (2005)b [133] Sleep hygiene TaU Mood/affect POMS 7 7 1.00
Espie et al. (2008) [81] CBTi Sleep hygiene Anxiety HADS-A 67 39 0.52*
Depression HADS-D 67 39 0.59**
Espie et al. (2014) [134] CBTi TaU Anxiety DASS-A 40 47 0.79***
Depression DASS-D 40 47 0.94***
Stress DASS-S 40 47 0.93***
Espie et al. (2019) [135] CBTi WLC Anxiety GAD-7 411 495 0.31***
Depression PHQ-9 411 495 0.39***
Falloon et al. (2015) [136] Sleep restriction Sleep hygiene Anxiety GAD-7 43 50 0.50*
Depression PHQ-9 43 50 0.27
Felder et al. (2020) [137] CBTi TaU Depression EPDS 88 91 0.40**
Anxiety GAD-7 88 90 0.37*
Freeman et al. (2015) [138] CBTi TaU Delusions PSYRATS 23 25 0.24
Hallucinations PSYRATS 23 25 0.23
Paranoia GPTS 20 25 0.28
Psychosis PANSS tot 21 24 0.07
Freeman et al. (2017) [139] CBTi TaU Anxiety GAD-7 603 971 0.26***
Depression PHQ-9 603 971 0.35***
Hallucinations SPEQ 603 971 0.27***
Paranoia GPTS 603 971 0.27***
Garland et al. (2014) [140] CBTi Mindfulness Mood/affect POMS 40 32 0.19
Stress CeSOSI 40 32 0.26
Garland et al. (2019) [141] CBTi Acupuncture Anxiety HADS-A 73 75 0.02
Depression HADS-D 73 75 0.09
Germain et al. (2012) [142] CBTi þ IRT Prazosin placebo Anxiety BAI 12 12 0.28
Depression BDI 12 12 0.36
PTSD PCL 12 12 0.46
Glozier et al. (2019) [143] CBTi Sleep education Depression CES-D 31 28 0.03
Ham et al. (2020) [144] CBTi Sleep hygiene Depression CES-D 24 20 0.56
Ho et al. (2014)a [145] CBTi þ telephone support WLC Anxiety HADS-A 49 33 0.21
Depression HADS-D 49 33 0.13
Ho et al. (2014)b [145] CBTi WLC Anxiety HADS-A 45 33 0.19
Depression HADS-D 45 33 0.16
Irwin et al. (2014)a [146] CBTi WLC Depression IDS-C 46 11 0.63
Irwin et al. (2014)b [146] Tai Chi WLC Depression IDS-C 39 12 0.22
Jansson-Frojmark et al. (2012) [147] CBTi WLC Anxiety HADS-A 15 15 1.19**
Depression HADS-D 15 15 1.12**
Jernelov et al. (2012)a [148] CBTi þ telephone support WLC Mood/affect CORE-OM 44 22 0.50
Stress PSS 44 22 0.64*
Jernelov et al. (2012)b [148] CBTi WLC Mood/affect CORE-OM 45 22 0.39
Stress PSS 45 22 0.30
Jungquist et al. (2012) [149] CBTi Self-monitoring Depression BDI 14 4 2.44***
Kaldo, V et al. (2015) [150] CBTi Mindfulness þ sleep
hygiene þ relaxation
Stress PSS 54 53 0.00
Kalmbach et al. (2019)a [151] CBTi Sleep hygiene Depression BDI-II 42 20 0.45
Rumination ERRI 42 20 0.17
Rumination PSWQ 42 20 0.38
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Table 2 (continued )
Author (year) Intervention Control Outcome Measure ne nc gþ
Kalmbach et al. (2019)b [151] CBTi Sleep hygiene Depression BDI-II 34 20 0.51
ERRI 34 20 0.08
PSWQ 34 20 0.53
Katofsky et al. (2012) [152] CBTi þ sleep medication Sleep medication Depression BDI 41 39 0.11
Kyle et al. (2020) [153] CBTi WLC Depression PHQ-9 136 166 0.53***
Anxiety GAD-7 136 166 0.33**
Lancee et al. (2012)a [154] CBTi (digital) WLC Anxiety HADS-A 109 92 0.17
Depression CES-D 109 42 0.23
Lancee et al. (2012)b [154] CBTi (booklet) WLC Anxiety HADS-A 126 91 0.02
Depression CES-D 126 41 0.03
Lancee et al. (2013) [155] CBTi CBTi (self-help) Anxiety HADS-A 102 95 0.16
Depression CES-D 102 95 0.32*
Lee et al. (2020) [156] Acupuncture WLC Depression HADS-D 49 49 2.66***
Anxiety HADS-A 49 49 0.91***
Lichstein et al. (2013) [157] CBTi Hypnotic taper Anxiety STAI 22 18 0.35
Depression GDS 22 18 0.72*
Martinez et al. (2014) [158] CBTi Sleep hygiene Anxiety SCL-90-R 27 20 0.06
Depression SCL-90-R 27 20 0.37
McCrae et al. (2019) [159] CBTi WLC Anxiety STAI 24 23 0.42
Depression BDI 24 23 0.57
McCurry et al. (1998) [160] CBTi WLC Depression CES-D 20 9 0.08
Nguyen et al. (2017) [161] CBTi TaU Anxiety HADS-A 13 11 0.98*
Depression HADS-D 13 11 1.73***
Nguyen et al. (2019) [162] CBTi TaU Anxiety HADS-A 9 6 0.37
Depression HADS-D 9 6 1.51*
Norell-Clarke et al. (2015) [163] CBTi Relaxation þ sleep hygiene Depression BDI 24 20 0.33
Park et al. (2015) [164] Nordic walking General walking Depression BDI 12 12 1.10*
Peoples et al. (2019) [165] CBTi Sleep hygiene þ Armodafinil þ placebo Depression PHQ-9 30 30 0.97***
Raskind et al. (2013) [166] Prazosin Placebo Depression HAM-D 32 35 0.67**
Depression PHQ-9 32 35 0.69**
PTSD CAPS 32 35 0.83**
Sadler et al. (2018) [167] CBTi Sleep education Anxiety GAI 22 21 2.02***
Depression GDS 22 21 4.14***
Sato et al. (2019) [168] CBTi TaU Anxiety HADS-A 11 11 0.81
Depression CES-D 11 11 1.52**
Savard et al. (2005) [169] CBTi WLC Anxiety HADS-A 27 30 0.35
Depression HADS-D 27 30 0.27
Schiller et al. (2018) [170] CBTi WLC Burnout SMBQ 25 26 0.03
Sheaves et al. (2017) [171] CBTi TaU Suicidal ideation BSS 20 20 0.14
Psychosis PANSS pos 20 20 0.31
Psychosis PANSS neg 20 20 0.51
Psychosis PANSS tot 20 20 0.34
Sheaves et al. (2019) [172] CBT for nightmares TaU Anxiety DASS-A 11 9 0.65
Depression DASS-D 11 9 0.15
Dissociation DES-B 11 9 0.73
Hallucinations CAPS 11 9 0.10
Paranoia GPTS 11 9 0.82
Psychosis DES-B 11 9 0.73
Stress DASS-S 11 9 0.46
Suicidal ideation BSS 11 9 0.48
Song et al. (2020) [173] CBTi Sleep hygiene Depression BDI 12 13 0.07
Anxiety BAI 12 13 0.98*
Tek et al. (2014) [174] Eszopiclone Placebo Depression CDS 19 17 0.07
Psychosis PANSS-pos 19 17 0.32
Psychosis PANSS-neg 19 17 0.05
Psychosis PANSS-tot 19 17 0.10
Thiart et al. (2015) [175] CBTi WLC Rumination PSWQ 59 54 0.84***
Wagley (2010) [176] CBTi WLC Depression PHQ-9 24 10 1.55***
Wen et al. (2018) [177] Augmented acupuncture Standard acupuncture Depression HADS-D 43 46 1.01***
Yeung et al. (2011)a [178] Electroacupuncture Placebo acupuncture Depression HDRS 22 11 0.28
Yeung et al. (2011)b [178] Standard acupuncture Placebo acupuncture Depression HDRS 23 12 0.47
Zhang et al. (2020) [179] Acupuncture Sham acupuncture Depression SDS 46 44 3.56***
Anxiety SAS 46 44 3.93***
Zhu et al. (2018) [180] Tai Chi TaU Depression SDS 37 12 0.30
Note: *p < 0.05, **p < 0.01, ***p < 0.001. CBTi¼ cognitive behavioural therapy for insomnia, dx ¼ diagnosis, IRT¼ image rehearsal therapy, MH ¼mental health, ne ¼ number
of participants in intervention group, nc ¼ number of participants in the control group, PTSD ¼ post-traumatic stress disorder, TaU ¼ treatment as usual, WLC ¼ wait list
control. abSubscript indicates that the study reports multiple eligible interventions in the same study, in these situations both interventions were included as separate studies
in the analysis and the control was halved accordingly.
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outliers were defined as any effect size for which the confidence
intervals did not overlap with the confidence interval of the pooled
effect [72].We conducted a sensitivity analysis examining the effect
of outliers for each outcome by rerunning the analysis with any
outlying effect sizes removed.Subgroup analyses
Moderation analysis was conducted to identify variables that
were associated with the effect of improving sleep on mental
health outcomes. A minimum of three studies representing each
moderator level category was required in order to conduct
moderation analysis. For categorical variables, the analysis was
based on a mixed effects model, in that the pooling of effect sizes
within each moderator level was based on a random effects model,
while the comparison of effect sizes between levels was based on a
fixed effects model. The Q statistic was then used to assess whether
effect sizes were significantly different between moderator levels.
For continuous variables, sample-weighted meta-regression was
used to investigate the impact of the moderator on mental health
effect sizes.Data availability statement
All data and analysis code are freely available on the Open Sci-
ence Framework under a creative commons 4.0 license (for access,
see [73]).Results
Study selection
Fig. 1 shows the flow of records through the review. Systemic
searches of the published and grey literature retrieved a total of
21,733 records, which was reduced to 15,139 after duplicates were
removed. Of these records, 14,687 (97%) were excluded in the first
stage of screening, leaving 452 full-text records to be screened. Of
these records, 387 (86%) were cross-referenced against the review
eligibility criteria and excluded (see Fig. 1 for a breakdown of rea-
sons and Supplementary Materials 2 for a list of the studies
excluded at this stage), leaving 65 records for inclusion in themeta-
analysis.Study characteristics
Table 2 describes key characteristics of the included studies. The
65 studies provided 72 comparisons between an intervention that
successfully improved sleep quality vs. a control group.Participants
A total of N ¼ 8608 participants took part across the 72 in-
terventions. 38 of the comparisons (53%) included participants
with a comorbid physical or mental health problem, while 31 (43%)
reported no comorbid health problems, and 3 (4%) reported
insufficient detail to make a judgement. Of the 38 comparisons
including participants with comorbid health problems, 18 (47%)
reportedmental health diagnoses, and 20 (53%) had physical health
problems.6
Outcome measures
The majority of comparisons (61, 85%) reported a measure of
depression, but 33 (46%) reported a measure of anxiety, 6 (8%) re-
ported a measure of stress, 5 (7%) reported measures of psychosis
spectrum experiences (e.g., total, positive, and negative symptoms),
9 (13%) reported a measure of general mood, 2 (3%) reported post-
traumatic stress disorder outcomes, 2 (3%) reported measures of
suicidal ideation, 4 (6%) reported rumination outcomes, and 1 (2%)
reported a measure of psychological burnout.
Interventions and comparisons
Most interventions were multi-component CBTi (53, 74%), but
interventions also involved acupuncture (7, 10%), pharmacological
treatments (2, 3%), sleep hygiene alone (2, 3%), sleep restriction
alone (2, 3%), Tai Chi (2, 3%), CBT for nightmares (1, 2%), herbal
remedies (1, 2%), walking (1, 2%), and yoga (1, 2%). Interventions
were most often compared against an active control group (34,
47%), but were also compared to waitlist control groups (25, 35%),
and groups receiving treatment as usual (13, 18%). On average
participants’ mental health was followed-up 20.5 weeks post-
intervention (median ¼ 12 weeks post-intervention), with the
earliest follow-up being 4-weeks post-intervention, and the
furthest follow-up 156-weeks (three years) post intervention.
Manipulation check: did sleep quality improve significantly in the
intervention group relative to controls?
Before we examined the effect of improving sleep quality on
subsequent mental health, we confirmed that studies included in
the review successfully improved sleep quality. The interventions
had large and statistically significant effects on sleep quality at the
earliest follow-up point reported (gþ ¼ 1.07, 95% CI ¼ 1.26
to 0.88, p < 0.001), although heterogeneity between studies was
substantial (I2 ¼ 79%, Q ¼ 331.93, p < 0.001). After twelve outlying
effect sizes were removed, the effect of the interventions on sleep
quality remained large and statistically significant (gþ ¼ 0.97, 95%
CI ¼ 1.07 to 0.88, p < 0.001), and heterogeneity was reduced to
moderate levels (I2 ¼ 43%, Q ¼ 102.32, p < 0.001). These findings
suggest that the primary studies included in the present review
successfully manipulated sleep quality, even after accounting for
outliers.
What effect do improvements in sleep quality have on mental
health?
Table 3 presents the effect of improving sleep quality on com-
posite mental health outcomes, and on measures of depression,
anxiety, stress, psychosis spectrum experiences, suicidal ideation,
PTSD, rumination, and burnout.
Composite mental health
On average, the 72 interventions that successfully improved
sleep quality had a statistically significant, medium-sized effect on
subsequent composite mental health outcomes, (gþ ¼ 0.53, 95%
CI ¼ 0.68 to 0.38, p < 0.001); however, there was substantial
heterogeneity between the effect sizes, (I2 ¼ 76%, Q ¼ 291.94,
p < 0.001). After re-running the analysis with eleven outlying effect
sizes removed, the effect of improving sleep on composite mental
health outcomes was small-to-medium sized but still statistically
significant, (gþ ¼ 0.42, 95% CI ¼ 0.49 to 0.34, p < 0.001) and
Fig. 1. PRISMA diagram showing the flow of studies through the review.
Table 3
The effect of improving sleep on mental health outcomes.
Outcome gþ 95% CI I2 Q k N
Composite outcomes 0.53*** 0.69 to 0.38 76% 291.94*** 72 8608
Depression 0.63*** 0.84 to 0.43 81% 322.03*** 61 7868
Anxiety 0.51*** 0.77 to 0.24 82% 186.92*** 35 5819
Stress 0.42* 0.79 to 0.05 55% 11.05 6 419
Psychosis spectrum
PANSS total 0.17 0.53 to 0.19 0% 0.41 3 121
Positive symptoms 0.26* 0.43 to 0.08 0% 1.71 5 1715
Negative symptoms 0.28 3.22 to 2.65 0% 1.00 2 76
Suicidal ideation 0.10 3.74 to 3.94 20% 1.25 2 60
PTSD 0.72 2.90 to 1.46 0% 0.59 2 91
Rumination 0.49* 0.93 to 0.04 36% 4.65 4 355
Burnout 0.03 0.58 to 0.52 e e 1 51
Notes: ***p < 0.001, *p < 0.05, PANSS ¼ Positive and Negative Symptoms Scale,
PTSD ¼ Post Traumatic Stress Disorder.
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Fig. 2 for a forest plot.Depression
Interventions that successfully improved sleep quality had a
statistically significant, medium-sized effect on depression across
61 comparisons, (gþ ¼ 0.63, 95% CI ¼ 0.83 to 0.43, p < 0.001);
however, once again, therewas substantial heterogeneity, (I2¼ 81%,
Q ¼ 322.09, p < 0.001). After re-running the analysis with nine
outlying effect sizes removed, the effect of improving sleep on
depression remained medium-sized, (gþ ¼ 0.47, 95% CI ¼ 0.57
to 0.37, p < 0.001), with moderate heterogeneity, (I2 ¼ 32%,
Q ¼ 74.86, p ¼ 0.0164). See Fig. 3 for a forest plot.7
Anxiety
Interventions that successfully improved sleep quality had a
statistically significant, small-to-medium sized effect on anxiety
across 35 comparisons, (gþ ¼ 0.50, 95% CI ¼ 0.76 to 0.24,
p < 0.001), with substantial levels of heterogeneity, (I2 ¼ 82%,
Q ¼ 187.02, p < 0.001). After re-running the analysis with four
outlying effect sizes removed, the effect improving sleep on anxiety
outcomes was small-to-medium sized, but still statistically signif-
icant, (gþ ¼ 0.38, 95% CI ¼ 0.49 to 0.27, p < 0.001), with lower
levels of heterogeneity, (I2 ¼ 43%, Q ¼ 52.49, p ¼ 0.0067). See Fig. 4
for a forest plot.Stress
Interventions that successfully improved sleep quality had a
statistically significant, small-to-medium sized effect on stress
(gþ ¼ 0.42, 95% CI ¼ 0.79 to 0.05, p ¼ 0.033), across six com-
parisons. There were moderate levels of heterogeneity (I2 ¼ 55%,
Q ¼ 11.05, p ¼ 0.05), but there were no outlying effect sizes. See
Fig. 5 for a forest plot.Psychosis spectrum experiences
Interventions that successfully improved sleep quality had a
small effect on total symptoms as indicated by the PANSS
(gþ ¼ 0.17, 95% CI ¼ 0.53 to 0.19, p ¼ 0.18) across three com-
parisons, with zero heterogeneity (I2 ¼ 0%, Q ¼ 0.41, p ¼ 0.813).
Interventions that successfully improved sleep quality had a small
effect on positive symptoms (gþ ¼ 0.26, 95% CI ¼ 0.43 to 0.08,
p ¼ 0.014) across five comparisons, with zero heterogeneity
(I2 ¼ 0%, Q¼ 1.71, p¼ 0.788). Finally, interventions that successfully
improved sleep quality had a small effect on negative symptoms
Fig. 2. Forest plot showing the effect of improving sleep on composite mental health outcomes.
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Fig. 3. Forest plot showing the effect of improving sleep on depression.
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comparisons, with zero heterogeneity (I2 ¼ 0%, Q ¼ 1, p ¼ 0.318).
See Fig. 6 for a forest plot.
Suicidal ideation
Interventions that successfully improved sleep quality had a
small, adverse effect on suicidal ideation (gþ ¼ 0.10, 95% CI ¼ 3.74
to 3.94, p ¼ 0.804) across two comparisons. There were low levels9
of heterogeneity (I2 ¼ 20%, Q ¼ 1.25, p ¼ 0.263) and no outlying
effect sizes. See Fig. 5 for a forest plot.
Post-traumatic stress disorder (PTSD)
Interventions that successfully improved sleep quality had a
medium-to-large effect on PTSD (gþ ¼ 0.72, 95% CI ¼ 2.90 to
1.46, p ¼ 0.149) across two comparisons, with zero heterogeneity
(I2 ¼ 0%, Q ¼ 0.59, p ¼ 0.442). See Fig. 5 for a forest plot.
Fig. 4. Forest plot showing the effect of improving sleep on anxiety.
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Interventions that successfully improved sleep quality had a
statistically significant, medium sized effect on rumination
(gþ ¼ 0.49, 95% CI ¼ 0.93 to 0.04, p ¼ 0.041) across four
comparisons, with moderate heterogeneity (I2 ¼ 36%, Q ¼ 4.65,
p ¼ 0.1991). See Fig. 5 for a forest plot.
Burnout
Only one study reported the effect of improving sleep on burnout
finding almost zero effect (g ¼ 0.03, CI ¼ 0.58 to 0.52, p ¼ 0.917).
Moderators of the effect of improving sleep quality on composite
mental health outcomes
Table 4 presents the findings of analyses evaluating categorical
moderators of the effect of improving sleep quality on composite
mental health outcomes and Table 5 presents analyses evaluating
continuous moderators using meta-regression. Studies that found
significant effects of the intervention on sleep quality reported
larger effects on subsequent composite mental health, (g ¼ 0.53,
95% CI ¼0.68 to 0.38, p < 0.001), than studies that did not find a
significant effect of the intervention on sleep quality, (g ¼ 0.12,
95% CI ¼ 0.24 to 0.01, p ¼ 0.0522), a difference that was statisti-
cally significant, (Q ¼ 17.59, p < 0.001). This finding strengthens the
notion that improvements in sleep are behind improvements in10mental health. The effect of improving sleep on mental health was
larger in studies with shorter follow-up periods, (i.e., <6 months,
gþ¼0.60), than in studies with longer follow-ups, (i.e., 6 months,
gþ ¼ 0.18, Q ¼ 10.75, p < 0.01). Furthermore, interventions that
were delivered face-to-face by a clinician or therapist were asso-
ciated with significantly larger effects on mental health,
(gþ ¼ 0.63), than those that were self-administered by partici-
pants, (gþ¼0.34, Q¼ 4.50, p < 0.05). Finally, there was significant
variation in the size of the effect between countries (Q ¼ 53.69,
p < 0.001). No other statistically significant categorical moderator
effects were found. Regarding continuous moderators, meta-
regression revealed a statistically significant doseeresponse effect
for the association between the effect of interventions on sleep
quality and the effect on subsequent mental health outcomes
(B ¼ 0.77, 95% CI ¼ 0.52 to 1.02, p < 0.001), suggesting that greater
improvements in sleep led to greater improvements in mental
health. No other continuous variables significantly moderated the
effect of improving sleep on mental health.
Post-hoc moderation analysis
Is the smaller effect of improving sleep on mental health at longer
follow-ups associated with smaller effects on sleep quality?. We
conducted further (unplanned) post-hoc analysis to investigate
whether the smaller effect of improving sleep on mental health at
longer follow-ups was accompanied by a reduction in the
Fig. 5. Forest Plot Showing the Effect of Improving Sleep on Stress, Suicidal Ideation, PTSD, and rumination.
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intervention at shorter follow-ups reported larger improvements in
sleep quality, (g ¼ 1.03, 95% CI ¼ 1.27 to 0.78, p < 0.001), than
those reporting longer follow-ups (g ¼ 0.44, 95% CI ¼ 0.62
to 0.27, p < 0.001), a difference that was statistically significant,
(Q ¼ 14.38, p < 0.001). This suggests that the smaller effect of
improving sleep on mental health at longer follow-ups might be
driven by a smaller effect of the interventions on sleep quality at
longer follow-ups.
Can some of the effect of improved mental health be explained by CBTi
modules that target processes associated with mental health?.11Finally, although the present review excluded interventions that
specifically and directly targeted mental health, some CBTi pro-
tocols include modules that might target similar processes associ-
ated with some mental health difficulties (rumination around
sleep, catastrophizing over the effect of poor sleep etc.). Therefore,
we compared CBTi interventions with modules that could target
processes associated with mental health vs. interventions that did
not include these modules (e.g., sleep restriction alone, sleep hy-
giene alone, herbal tea, and pharmacological intervention). There
were no significant differences in the effect of improved sleep
quality on mental health between CBTi interventions including
modules addressing processes associated with mental health
Fig. 6. Forest plot showing the effect of improving sleep on psychosis spectrum outcomes.
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that did not (g¼0.48, 95% CI¼0.65 to0.32, p < 0.001, Q¼ 2.51,
p ¼ 0.285). This finding suggests that it is the beneficial effect of
improved sleep quality that confers improvements in mental
health rather than the inclusion of modules that target processes
associated with mental health commonly seen in CBTi protocols.
Risk of bias assessments
Fig. 7 summarizes the weighted assessment of risk of bias. In-
dividual risk of bias judgements for included studies are presented
in Supplementary Material 3. Ten studies (15%) were judged as
having low risk of bias, 29 studies (45%) were judged as high risk of
bias, and 26 studies (40%) were judged as unclear. The methodo-
logical quality of the included studies was not associated with the
effect of improving sleep on composite mental health outcomes,
Q ¼ 0.72, p ¼ 0.395.
Publication bias
A funnel plot of the effect of improving sleep quality on com-
posite outcomes revealed asymmetry in the effect sizes (Egger's
regression ¼ 1.09, 95% CI ¼ 1.91 to 0.28, p < 0.05, see Fig. 8).
Duval and Tweedie's [74] trim and fill procedurewas therefore used12to address the asymmetry. Ten studies were imputed resulting in a
statistically significant, small-to-medium sized adjusted effect of
improving sleep on composite mental health outcomes
(gþ ¼ 0.35, 95% CI ¼ 0.55 to 0.16, p < 0.001). Orwin's failsafe n
test suggested that an additional 4101 comparisons producing null
effects would be needed to reduce the average effect of improving
sleep on composite outcomes to zero. Taken together these results
suggest that the effect of improving sleep on composite mental
health is robust to possible publication bias.Discussion
The present review usedmeta-analysis to synthesize the effect of
72 interventions that improved sleep quality relative to a control
condition on subsequent mental health. The findings revealed that
improving sleep quality had, on average, a medium-sized effect on
mental health, including clear evidence that improving sleep
reduced depression, anxiety, and stress. A dearth of primary studies
of other mental health difficulties (e.g., psychosis spectrum experi-
ences, suicidal ideation, PTSD, rumination, and burnout) mean that
it is premature to draw definitive conclusions in these areas. It was
also notable that we found a doseeresponse relationship between
improvements in sleep quality and subsequent mental health, such
that greater improvements in sleep led to greater improvements in
Table 4
Categorical moderators of the effect of improving sleep on composite mental health outcomes.
Variable Levels k gþ 95% CI Q
Significant effect on sleepa Yes 72 0.53 0.69 to 0.38 17.69***
No 31 0.12 0.24 to 0.01
Clinical status of MH Clinical 15 0.72 1.14 to 0.30 0.92
Non-clinical 45 0.50 0.68 to 0.31
Comorbidities Mental health 18 0.64 1.00 to 0.29 0.63
Physical health 20 0.54 0.76 to 0.32
No comorbidities 31 0.47 0.72 to 0.23
Follow-up point Short (<6 months) 61 0.60 0.77 to 0.42 10.75**
Long (6 months) 11 0.18 0.36 to 0.00
Assessment type Self-reported 66 0.54 0.70 to 0.38 0.62
Clinician rated 6 0.44 0.65 to 0.23
Adjusted data Adjusted 21 0.51 0.77 to 0.26 0.01
Unadjusted 51 0.53 0.72 to 0.35
Recruitment setting Clinical (MH) 12 0.52 1.00 to 0.04 3.72
Clinical (PH) 14 0.52 0.76 to 0.28
Community 39 0.39 0.53 to 0.26
Mixed 9 1.12 1.94 to 0.31
Recruitment method Voluntary 49 0.46 0.58 to 0.34 0.98
Health professional 7 0.65 1.45 to 0.14
Mixed 8 0.88 1.80 to 0.04
Control group Active control 34 0.58 0.87 to 0.30 0.57
TaU 13 0.52 0.75 to 0.29
Wait-list 25 0.46 0.63 to 0.29
Risk of bias High 31 0.38 0.56 to 0.21 0.74
Low 10 0.55 0.91 to 0.20
Intervention type Acupuncture 7 1.17 2.08 to 0.25 2.46
CBTi 53 0.44 0.59 to 0.29
Exercised basedb 4 0.52 0.85 to 0.19
Pharmacologicalc 2 e e
Sleep hygiene onlyc 2 e e
Sleep restriction onlyc 1 e e
CBT for nightmaresc 1 e e
Herbal teac 1 e e
Intervention format Group 11 0.42 0.92 to 0.08 0.25
Individual 52 0.55 0.73 to 0.38
Intervention delivery Clinician delivered 43 0.63 0.87 to 0.38 4.50*
Self-administered 23 0.34 0.43 to 0.26
Country of origin Australia 5 1.50 2.39 to 0.60 53.69***
Canada 4 0.12 0.40 to 0.17
China 8 0.85 1.59 to 0.11
Germany 3 0.49 0.90 to 0.08
Korea 4 0.78 1.70 to 0.15
Netherlands 3 0.16 0.29 to 0.03
Sweden 8 0.28 0.53 to 0.03
Taiwan 4 0.57 0.61 to 0.52
UK 9 0.36 0.51 to 0.22
USA 20 0.50 0.71 to 0.28
New Zealandc 2 e e
Spainc 1 e e
Notes: CBTi ¼ cognitive behavioural therapy for insomnia, MH ¼ Mental Health, PH ¼ Physical Health, TaU ¼ treatment as usual, WLC ¼ wait list control.
*p < 0.05, **p < 0.01, ***p < 0.001.
a Studies in the ‘No’ moderator category were excluded from the review due to having no significant effect on sleep quality but were included for moderation analysis.
b The ‘exercise based’ category combines separate interventions with exercise as a key element, including walking, yoga and Tai Chi.
c Not included in subgroup analysis due to low number.
Table 5
Continuous moderators of the effect of improving sleep on composite mental health
outcomes.
Variable k B SE 95% CI
Publication year 72 0.02 0.02 0.05 to 0.02
Journal impact 71 0.01 0.01 0.01 to 0.03
Age 71 0.00 0.01 0.01 to 0.02
Sex 71 0.00 0.00 0.00 to 0.01
Sleep effect 70 0.77*** 0.13 0.52 to 1.02
Intervention duration 70 0.02 0.02 0.03 to 0.06
Contact time 55 0.00 0.01 0.02 to 0.01
Number of sessions 61 0.00 0.01 0.02 to 0.01
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13mental health. Although there was some evidence of publication
bias, the effects remained robust to correction. Taken together, the
findings suggest that improving sleep leads to better mental health,
therefore providing strong evidence that sleep plays a causal role in
the experience of mental health difficulties.
Sleep as a transdiagnostic treatment target
The present findings support the idea that targeting sleep
promotes mental health across a range of populations and expe-
riences. The effect of improving sleep quality on composite mental
health was medium-sized and statistically significant, regardless
Fig. 7. Weighted risk of bias summary plot.
Fig. 8. Contrast enhanced funnel plot for the effect of improving sleep on composite mental health (solid grey markers) with imputed studies (hollow markers).
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This finding is particularly important given the healthcare chal-
lenges associated with multimorbidity [75] and mental and
physical health problems often co-occur [76e79], something that
appears to be increasing [80]. Consequently, it is important that
the benefits of improving sleep on mental health occur even in the
presence of comorbid health complaints, as was reported in the
present research. Improving sleep has also been shown to improve
aspects of physical health, including fatigue [81], chronic pain
[82,83], and overall health related quality of life [84] and could
reduce the cost of healthcare. For example, offering a digital CBTi
intervention (Sleepio) to primary care patients was associated
with an average saving of £70.44 per intervention user [85], and
cost savings following sleep intervention have also been specif-
ically reported in people with comorbid mental health difficulties
such as depression [86].
Another finding to suggest that targeting sleep could promote
mental health across a range of populations and experiences, is that
we found no difference in the effect of improving sleep quality on
mental health between those with clinically defined mental health
difficulties and those with non-clinical experiences or between
those recruited from clinical vs. community settings, with both
groups receiving significant benefits of improved sleep on mental
health. This suggests that improving sleep could prove helpful
across a range of mental health severities, thus broadening the
possible impact of sleep interventions within healthcare services.
Finally, there is growing evidence that sleep disturbances predict
the development of mental health difficulties in the future. For14example, shorter and more variable sleep has been shown to be
longitudinally associated with more severe hallucinations and
delusional ideation in those at high-risk of psychosis [87]. The
present research found that improving sleep has a significant
beneficial impact on futuremental health in thosewith non-clinical
experiences, raising the possibility that delivering interventions
that improve sleep early might limit the risk of developing (or
exacerbating) substantive mental health difficulties. Indeed, less
severemild-to-moderate presentations of mental health difficulties
can develop over time into more severe mental health diagnoses
[88,89], therefore improving sleep might be one tool that can be
used in combination with others to limit the risk of transition.
Strengths and limitations
The present review has several strengths. First, it provides a
comprehensive andup-to-date searchofRCTs examining theeffectof
improving sleep on a variety of subsequent mental health outcomes.
Indeed,with65RCTs andN¼8608participants, thepresent review is
one of the largest studies of the effect of improving sleep on mental
health to date. Second, the review was specifically designed to test
the causal association between sleep and mental health (i.e., RCTs
only, successful sleep improvement required, temporal lag between
measures etc.). To our knowledge, the review is thefirst to adopt this
approach in thefield of sleepandmental health, although thegeneral
approach has been used in other fields [90]. Finally, we provide an
analysis of possible moderators of the effect of improving sleep on
mental health, identifying several key moderators of the effect.
Practice points
 Sleep is causally related to the experience of mental
health difficulties and represents a viable transdiagnostic
treatment target for those experiencing mental health
difficulties.
 Improving sleep has beneficial effects on the experience
of mental health difficulties, regardless of the severity of
those difficulties, or the presence of comorbid health
conditions.
 Healthcare professionals aiming to improve mental
health (particularly depression, anxiety, and stress)
should consider interventions designed to improve sleep,
particularly cognitive behavioral therapy for insomnia
where the evidence base is strongest.
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interpreting the findings. First, relatively few studies examined the
effect of improving sleep over the long term. Those that did report
longer follow-ups generally found smaller effects (although still sta-
tistically significant), most likely due to the diminishing effects of
interventions on sleep quality over time [91]. Consequently, it is
important that interventions targeting sleep quality as a route to
improving mental health seek to maintain their beneficial effects.
Second, there were few primary studies for some of the outcomes
included in this review. Consequently, in lieu of more studies
reporting theseoutcomes, the inferences thatwecanmake formental
health outcomes other thandepression and anxiety aremore limited.
Third, although the intention of the present review was to include a
broad range of sleep disturbances, most of the analyses are based on
CBT interventions for insomnia. Thismight be due to the relationship
between insomniaandmentalhealthbeing theone that ishistorically
most studied. However, it may be that our focus on sleep quality
precluded some studies that donot focus on insomnia from inclusion.
For example, different sleep disorders have different conceptualisa-
tions of improvement that might not include sleep quality. For
example, the timing of sleep is particularly important in circadian
rhythm disorders and daytime sleepiness is a key outcome in sleep
apnoea research. Future researchmight consider examining the effect
of improving specific sleep disorders on mental health by con-
ceptualising improvements using sleep disorder specific outcomes.
Future directions
The present review highlighted several areas for future research
in terms of both research and theory, and the implementation of
findings in practice. First, given that mental health was measured
on average around 20.5 weeks post-intervention in the primary
studies, and that the effect of improving sleep on mental health
significantly reduced over time, future research should examine the
effect of improving sleep on mental health over the longer term.
Second, although not uncommon, the majority of RCTs included in
the present review were at high risk, or unclear risk or bias.
Consequently, in addition to studying the effect of improving sleep
over the longer term, on a range of mental health difficulties
beyond depression and anxiety, we need more research at lower
risk of methodological bias.
Finally, although the present research provides evidence for a
causal association between sleep and mental health, it is less clear
how sleep effects mental health. One potential mechanism is
whether and how people regulate their emotions (e.g., in response
to negative events). Indeed, evidence suggests that poor sleep can
amplify the adverse effect of negative life events [92,93], dull the
beneficial impact of positive events [94], and is associated with
more frequent use of emotion regulation strategies that might be
detrimental to good mental health [95]. By extension, although we
are unaware of RCTs testing the effect of improved sleep on
emotion regulation, changes in sleep are prospectively associated
with changes in aspects of emotion regulation [96,97], while
experimentally induced sleep deprivation is adversely linked to
poorer emotion regulation [96,97]. Contemporary perspectives on
emotion regulation (e.g., the action control perspective), draw on
research on how people regulate their behaviour, to propose that
regulating emotions involves three tasks, 1) identifying the need to
regulate, 2) deciding whether and how to regulate, and 3) enacting
a regulation strategy [98]. We propose that poor sleep quality has
the potential to adversely affect anyone (or all) of the three tasks
involved in effectively regulating emotions, which might go some
way toward explaining the relationship between poor sleep and
mental health. Therefore, we would recommend that future
research includes measures of aspects of emotion regulation (e.g.,15the Difficulties in Emotion Regulation Scale, [99]) within experi-
mental and longitudinal designs to elucidate possible mechanisms
by which improvements in sleep benefit mental health.
In terms of practice and implementation, evidence on the effect
of sleep on mental health also supports calls for routine screening
and treatment of problems with sleep. Both the Royal Society for
Public Health (RSPH) and the Mental Health Foundation (MHF)
recommend that primary health care training should include
awareness of, and skills in assessing, sleep problems [100,101].
Despite this and a growing body of evidence, there has been little
progress to date [102]. This may reflect under-appreciation of the
importance of sleep [103] and lack of training and skills in
assessing and managing sleep problems [104e108], as well as
limited time and resources [103,109]. Therefore, a profitable next
step might be to explore barriers and facilitators to assessing sleep
and delivering effective interventions in specific care settings,
from both the patient and clinician perspective. Indeed, the pre-
sent review also highlighted a dearth of trials that tested the effect
of improving sleep on mental health outcomes in ‘real world’
settings (e.g., within existing clinical and community health ser-
vices). Although some researchers are taking important steps in
this area [110e112], there is a clear need for more trials of in-
terventions in clinical services so that the effectiveness and
implementation of such interventions in routine care can be better
understood.
Conclusions
Taken together, the present research supports the view that
sleep is causally related to the experience of mental health diffi-
culties, and therefore that sleep represents a viable treatment
target that can confer significant benefits to mental health, as it has
been found to do for physical health. We found that improving
sleep was associated with better mental health regardless of the
severity of mental health difficulty (i.e., clinical vs. non-clinical) or
the presence of comorbid health conditions. Poor sleep is almost
ubiquitous within mental health services [102,108,113,114], is
causally related to the experience of mental health difficulties, and
represents a potential treatment target [105,115,116]. Consequently,
equipping health professionals with greater knowledge and re-
sources to support sleep is an essential next step. Future research
should consider how interventions that improve sleep could be
better incorporated into routine mental health care, as well as the
possible mechanisms of action that might explain how sleep exerts
its effects on mental health.
Research agenda
To fully harness the effect of improved sleep on mental
health, it is important that future research:
1. Explores the barriers and possible solutions to incorpo-
rating interventions that improve sleep into mental
health care services.
2. Tests the effect of improving sleep on mental health
outcomes beyond depression and anxiety, and over the
long term, using designs at low risk of methodological
bias.
3. Investigates the possible mechanisms of action that
might explain how sleep exerts its effects on the expe-
rience of mental health difficulties.
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